Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma

被引：1

作者：

Haughney, John ^{[1
]}

Tran, Trung N. ^{[2
]}

Heatley, Heath ^{[3
]}

Bourdin, Arnaud ^{[4
]}

Menzies-Gow, Andrew ^{[5
]}

Jackson, David J. ^{[6
,7
]}

Maslova, Ekaterina ^{[8
]}

Chapaneri, Jatin ^{[8
]}

Skinner, Derek ^{[3
]}

Carter, Victoria ^{[3
]}

Chan, Jeffrey Shi Kai ^{[3
]}

Price, David ^{[3
,9
]}

机构：

[1] NHS Clin Res Facil, Glasgow, Scotland

[2] AstraZeneca, Gaithersburg, MD USA

[3] Observat & Pragmat Res Inst, Singapore, Singapore

[4] Montpellier Univ Hosp, Arnaud Villeneuve Hosp, Dept Resp Dis, Montpellier, France

[5] Royal Brompton & Harefield Hosp, UK Severe Asthma Network & Natl Registry, London, England

[6] Kings Coll London, Guys & St Thomas NHS Trust, UK Severe Asthma Network & Natl Registry, London, England

[7] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England

[8] AstraZeneca, Cambridge, England

[9] Univ Aberdeen, Ctr Acad Primary Care, Div Appl Hlth Sci, Aberdeen, Scotland

来源：

NPJ PRIMARY CARE RESPIRATORY MEDICINE | 2023年 / 33卷 / 01期

关键词：

OUTCOMES; BURDEN;

D O I：

10.1038/s41533-023-00331-0

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n = 476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma only had short gaps (<90 days) between oral corticosteroid prescriptions sometime during follow-up. The increasing frequency pattern was more likely in patients with greater asthma severity and with more short-acting beta(2)-agonist use at baseline. Our approach may provide a clinically relevant representation of intermittent oral corticosteroid use in asthma.

引用

页数：5

共 17 条

[1] [Anonymous], 2020, OPTIMUM PATIENT CARE
[2] Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the mutt country, cross-sectional SABINA III study
Bateman, Eric D.
Price, David B.
Wang, Hao-Chien
Khattab, Adel
Schonffeldt, Patricia
Catanzariti, Angelina
van der Valk, Ralf J. P.
Beekman, Maarten J. H., I
[J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (05)
[3] Bengtson LGS, 2017, J MANAG CARE SPEC PH, V23, P1149, DOI 10.18553/jmcp.2017.23.11.1149
[4] Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
Bleecker, Eugene R.
Menzies-Gow, Andrew N.
Price, David B.
Bourdin, Arnaud
Sweet, Stephen
Martin, Amber L.
Alacqua, Marianna
Trung N Tran
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (03) : 276 - 293
[5] Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN
[6] The CPRD and the RCGP: building on research success by enhancing benefits for patients and practices
Kousoulis, Antonis A.
Rafi, Imran
de Lusignan, Simon
[J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2015, 65 (631) : 54 - 55
[7] Burden of systemic glucocorticoid-related complications in severe asthma
Lefebvre, Patrick
Duh, Mei Sheng
Lafeuille, Marie-Helene
Gozalo, Laurence
Desai, Urvi
Robitaille, Marie-Noelle
Albers, Frank
Yancey, Steve
Ortega, Hector
Forshag, Mark
Lin, Xiwu
Dalal, Anand A.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 57 - 65
[8] Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States
Lugogo, Njira
Gilbert, Ileen
Tkacz, Joseph
Gandhi, Hitesh
Goshi, Nadia
Lanz, Miguel J.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 681 - +
[9] National Institute for Health and Care Excellence, 2021, NICE GUID NG08 ASTHM
[10] Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
Nwaru, Bright I.
Ekstrom, Magnus
Hasvold, Pal
Wiklund, Fredrik
Telg, Gunilla
Janson, Christer
[J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (04)

← 1 2 →